Heilongjiang Dier Pharmaceutical

Heilongjiang Dier Pharmaceutical is a comprehensive pharmaceutical enterprise based in Harbin, China, specializing in the research, development, and manufacturing of chemical drugs and traditional Chinese medicine extracts. The company is particularly recognized for its leadership in hepatology, producing a widely used range of Compound Glycyrrhizin products for the treatment of chronic liver diseases and inflammatory skin conditions. With multiple GMP-certified production lines, Dier Pharmaceutical manufactures a diverse portfolio of dosage forms, including large and small volume injections, tablets, and capsules. The company serves as a significant player in the regional pharmaceutical industry of Northeast China, focusing on high-tech manufacturing and the modernization of traditional therapies. Its products are distributed extensively across the domestic Chinese market to address needs in cardiovascular, respiratory, and dermatological health.